ADAG
Adagene Inc
NASDAQ: ADAG · HEALTHCARE · BIOTECHNOLOGY
$3.55
+0.57% today
Updated 2026-04-29
Market cap
$234.56M
P/E ratio
—
P/S ratio
30.58x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$1 – $5
Volume
0.3M
Adagene Inc (ADAG) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.26M | $-18.15M | $-28.53M | $-43.41M | $-48.61M | $-28.45M | $-29.70M | $-15.66M |
| Capital expenditures | $514703.00 | $151829.00 | $935199.00 | $2.51M | $690938.00 | $85012.00 | $33580.00 | $17053.00 |
| Depreciation | $909002.00 | $816686.00 | $858408.00 | $1.13M | $1.45M | $1.21M | $926248.00 | — |
| Stock-based comp | $126540.00 | $611711.00 | $10.13M | $18.68M | $10.52M | $7.27M | $4.91M | $3.74M |
| Free cash flow | $-14.78M | $-18.31M | $-29.46M | $-45.92M | $-49.30M | $-28.54M | $-29.73M | $-15.67M |
| Investing cash flow | $-29.51M | $24.86M | $7.07M | $-2.51M | $-686046.00 | $-77356.00 | $1.11M | — |
| Financing cash flow | $51.06M | $69.69M | $4.44M | $145.36M | $17.82M | $-5.37M | $3.77M | — |
| Dividends paid | — | — | — | $4.61M | $322827.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |